The da Vinci anchors DEPLOY's surgical category as the verified-at-scale benchmark. Every other surgical entrant (Medtronic Hugo, J&J Ottava) is measured against its transparently disclosed installed base.
✔
Per Intuitive's SEC filings, 11,395 da Vinci systems and 1,041 Ion systems are installed, and the fifth-generation da Vinci 5 was FDA cleared in March 2024 with force feedback.
Price
No reviewed price is on record. We do not treat unverified analyst estimates as pricing data. There is no consumer price. The da Vinci is enterprise B2B equipment sold to hospitals on multi-million-dollar per-system contracts, so DEPLOY records zero price points rather than a consumer figure.
Availability
Internal use only
The da Vinci is sold to hospitals and surgical centers, not consumers. Per Intuitive's SEC filings, 11,395 da Vinci systems and 1,041 Ion systems are installed worldwide.
Real-world status
The da Vinci is the verified-at-scale anchor of surgical robotics, the benchmark every other entrant is measured against. The lineup spans da Vinci multi-port (X/Xi), the single-port SP, the fifth-generation da Vinci 5 (FDA cleared March 2024, with force feedback), and the Ion bronchoscopy robot (FDA 2019). It is teleoperated: a surgeon controls every motion, with shipped analytics AI. Autonomous-suturing work exists only as research demonstrations on da Vinci hardware, not as shipped product, so DEPLOY does not treat the da Vinci as an autonomous surgical robot.
⚠
The da Vinci is teleoperated, not autonomous: a surgeon controls every motion. Autonomous-suturing work on da Vinci hardware is research demonstration, not shipped product. Do not read 'surgical robot' as 'AI surgeon'.
⊘
There is no consumer price. The da Vinci is sold to hospitals on multi-million-dollar per-system contracts, so DEPLOY records zero price points rather than a consumer figure.
11,395 da Vinci systems and 1,041 Ion systems, per Intuitive's SEC filings🟢verified.
Can I buy a da Vinci?
Not as a consumer⊘absence. It is sold to hospitals and surgical centers on multi-million-dollar per-system contracts; there is no consumer price.
Is the da Vinci autonomous?
No, it is teleoperated🟢verified: a surgeon controls every motion. Autonomous-suturing work is research demonstration on da Vinci hardware🟠claimed, not shipped product.
What is the da Vinci 5?
The fifth-generation system, FDA cleared in March 2024🟢verified, which adds force feedback. Earlier systems are the multi-port X/Xi and single-port SP.
How does da Vinci compare to Hugo and Ottava?
Da Vinci is the verified-at-scale benchmark (11,395 installed)🟢verified; Medtronic Hugo is the commercial competitor (FDA urology-only, undisclosed count), and J&J Ottava is pre-market.
Pricing and availability are tagged verified or claimed against primary sources. Manufacturer targets are reported as targets, not prices you can pay today.